Mizumoto A, Sano I, Matsunaga Y, Yamamoto O, Itoh Z, Ohshima K
Gastrointestinal Laboratories, Gunma University, Maebashi, Japan.
Gastroenterology. 1993 Aug;105(2):425-32. doi: 10.1016/0016-5085(93)90716-p.
Motilin is known to induce gastric phase III contractions via neural pathways in vivo, but the local mechanism of action is not clearly determined.
An isolated perfused canine stomach was used to demonstrate the mechanism of motilin. Synthetic canine motilin at doses of 0.1, 0.3, 1.0, and 3.0 micrograms/h was infused intra-arterially, and effects of several receptor antagonists on motilin-induced contractions were examined.
The immunoreactive motilin concentration of venous effluent showed that motilin at doses of 0.1 and 0.3 microgram/h was within the physiological range. Each dose of motilin induced phasic contractions in the isolated stomach, and a dose-related increase in frequency was observed, but not their mean amplitude. Atropine, hexamethonium, ICS205-930, BRL43694, phentolamine, yohimbine, and propranolol significantly inhibited motilin-induced contractions. Naloxone, methysergide, and timolol did not affect the response of motilin. Prazosin significantly increased the mean amplitude of motilin-induced contractions.
Physiological dose of motilin can initiate phasic contractions in the stomach independently of the presence of the extrinsic nerves. The results suggest that cholinergic pathway, 5-hydroxytryptamine (HT)3 receptors, and alpha receptors are involved in the motilin-induced contractions.
已知胃动素在体内通过神经通路诱导胃的Ⅲ期收缩,但其局部作用机制尚未明确确定。
使用离体灌注犬胃来证明胃动素的作用机制。以0.1、0.3、1.0和3.0微克/小时的剂量动脉内输注合成犬胃动素,并检测几种受体拮抗剂对胃动素诱导收缩的影响。
静脉流出液中免疫反应性胃动素浓度表明,0.1和0.3微克/小时剂量的胃动素在生理范围内。各剂量的胃动素均在离体胃中诱导出相性收缩,且观察到频率呈剂量依赖性增加,但平均幅度未增加。阿托品、六甲铵、ICS205-930、BRL43694、酚妥拉明、育亨宾和普萘洛尔显著抑制胃动素诱导的收缩。纳洛酮、麦角新碱和噻吗洛尔不影响胃动素的反应。哌唑嗪显著增加胃动素诱导收缩的平均幅度。
生理剂量的胃动素可在无外在神经的情况下独立引发胃的相性收缩。结果表明,胆碱能通路、5-羟色胺(5-HT)3受体和α受体参与胃动素诱导的收缩。